„I would like to recommend Johannes. In the frame of a major variation for the complete change of synthesis for a peptide on the market worldwide, Johannes provided many insightfull recommendations and suggestions for improvement. He guided the regulatory approach in terms of compliance to CTD and EMEA/FDA drug master file registration procedures. We have now completed the sucessfull registration in all ICH countries and almost RoW. I strongly recommend Johannes both for his managerial and regulatory skills.“
Johannes van Gelderen
Lausanne, Waadt, Schweiz
1049 Follower:innen
500+ Kontakte
1049 Follower:innen
500+ Kontakte
Aktivitäten
-
I thought yesterday might be my last day with the Government, so I took a selfie as I was leaving. And I was RIF’d this morning after 15 years of…
I thought yesterday might be my last day with the Government, so I took a selfie as I was leaving. And I was RIF’d this morning after 15 years of…
Beliebt bei Johannes van Gelderen
-
Vanavond de eerste St. Michaël-iftar, met leerlingen, collega’s, de schoonmaaksters, groot succes!
Vanavond de eerste St. Michaël-iftar, met leerlingen, collega’s, de schoonmaaksters, groot succes!
Beliebt bei Johannes van Gelderen
-
Vier jij 75 jaar medezeggenschap met mij mee?
Vier jij 75 jaar medezeggenschap met mij mee?
Beliebt bei Johannes van Gelderen
Berufserfahrung
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Ausbildung
-
ARIAQ Institut de formation et conseil en management de la performance, Yverdon-les-Bains
–
Covering medical device manufacturing (including equipment qualification & process validation), essential requirements, risk management, usability engineering, post-marketing surveillance, quality management systems, handling of customer complaints, audits, biocompatability issues, software validation, microbiology and sterilisation.
-
–
-
–
Bescheinigungen und Zertifikate
-
Registered Member of TOPRA
The Organisation for Professionals in Regulatory Affairs
Sprachen
-
English
Verhandlungssicher
-
French
Verhandlungssicher
-
German
Verhandlungssicher
-
Dutch
Muttersprache oder zweisprachig
Erhaltene Empfehlungen
-
LinkedIn Mitglied
7 Personen haben Johannes van Gelderen empfohlen
Jetzt anmelden und ansehenWeitere Aktivitäten von Johannes van Gelderen
-
Oculis is pleased to announce that Sharon Klier, MD, Chief Development Officer, will present “Driving forward Phase 3 DIAMOND trials of OCS-01 eye…
Oculis is pleased to announce that Sharon Klier, MD, Chief Development Officer, will present “Driving forward Phase 3 DIAMOND trials of OCS-01 eye…
Beliebt bei Johannes van Gelderen
-
What no one tells you about being a CEO: 1. If you want to be the boss, first be the top performer where you are. 2. At the start, CEO is Chief…
What no one tells you about being a CEO: 1. If you want to be the boss, first be the top performer where you are. 2. At the start, CEO is Chief…
Beliebt bei Johannes van Gelderen
-
Shame on you! You demanded gratitude from a leader whose country is fighting for survival. You escalated a discussion that should have been about…
Shame on you! You demanded gratitude from a leader whose country is fighting for survival. You escalated a discussion that should have been about…
Beliebt bei Johannes van Gelderen
-
Great opportunity to hear about the latest developments and trends in #genetherapies and AAV production at the Cell & Gene Therapy Manufacturing 2025…
Great opportunity to hear about the latest developments and trends in #genetherapies and AAV production at the Cell & Gene Therapy Manufacturing 2025…
Beliebt bei Johannes van Gelderen
-
Hi network, I'm very happy to announce that I am starting a new position at Benchling. I'm excited to join the team and start supporting the same…
Hi network, I'm very happy to announce that I am starting a new position at Benchling. I'm excited to join the team and start supporting the same…
Beliebt bei Johannes van Gelderen
-
The biggest sign of leadership has nothing to do with titles. It shows up in the small moments most people ignore. Like how you treat the janitor…
The biggest sign of leadership has nothing to do with titles. It shows up in the small moments most people ignore. Like how you treat the janitor…
Beliebt bei Johannes van Gelderen
-
@Acadia Pharmaceuticals is #hiring in Europe! Join a passionate Regulatory Affairs team dedicated to innovating treatments and solutions for…
@Acadia Pharmaceuticals is #hiring in Europe! Join a passionate Regulatory Affairs team dedicated to innovating treatments and solutions for…
Beliebt bei Johannes van Gelderen
-
✨As the J.P. Morgan 2025 conference kicks off today, we're thrilled to share insights from our CEO, Bertrand Ducrey, on why Switzerland is a vibrant…
✨As the J.P. Morgan 2025 conference kicks off today, we're thrilled to share insights from our CEO, Bertrand Ducrey, on why Switzerland is a vibrant…
Beliebt bei Johannes van Gelderen
-
Telix has completed the installation of two new cyclotrons at Telix Manufacturing Solutions (TMS) in Brussels South, Belgium, facilitating the…
Telix has completed the installation of two new cyclotrons at Telix Manufacturing Solutions (TMS) in Brussels South, Belgium, facilitating the…
Beliebt bei Johannes van Gelderen
-
Telix today announces it has entered into an asset purchase agreement with antibody engineering company ImaginAb Inc. to acquire a pipeline of…
Telix today announces it has entered into an asset purchase agreement with antibody engineering company ImaginAb Inc. to acquire a pipeline of…
Beliebt bei Johannes van Gelderen
-
Santhera Pharmaceuticals (SIX: SANN) announces that China’s National Medical Products Administration (NMPA) has approved AGAMREE® (vamorolone) for…
Santhera Pharmaceuticals (SIX: SANN) announces that China’s National Medical Products Administration (NMPA) has approved AGAMREE® (vamorolone) for…
Beliebt bei Johannes van Gelderen
-
Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of…
Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of…
Beliebt bei Johannes van Gelderen